Dashboard
Poor long term growth as Operating profit has grown by an annual rate -5.87% of over the last 5 years
With a fall in Net Sales of -4.66%, the company declared Very Negative results in Sep 25
With ROE of 3.6, it has a Very Expensive valuation with a 1.5 Price to Book Value
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 2,524 Cr (Small Cap)
41.00
39
1.31%
-0.16
3.56%
1.44
Total Returns (Price + Dividend) 
Latest dividend: 2 per share ex-dividend date: Jul-30-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Nocil . Stock Falls to 52-Week Low of Rs.150.95 Amidst Prolonged Downtrend
Shares of Nocil . touched a fresh 52-week low of Rs.150.95 today, marking a significant decline amid a sustained downward trajectory over recent sessions. The stock has recorded a four-day consecutive fall, accumulating a loss of approximately 5% during this period, underperforming its sector peers and broader market indices.
Read More
Nocil . Stock Falls to 52-Week Low of Rs.150.95 Amidst Prolonged Downtrend
Shares of Nocil . touched a fresh 52-week low of Rs.150.95 today, marking a significant milestone in the stock’s ongoing decline. This new low comes after a series of consecutive sessions with negative returns, reflecting persistent pressures on the specialty chemicals company’s market valuation.
Read More
Nocil . Stock Falls to 52-Week Low of Rs.153.8 Amidst Continued Underperformance
Shares of Nocil . touched a fresh 52-week low of Rs.153.8 today, marking a significant decline amid ongoing subdued performance in the specialty chemicals sector. The stock has recorded losses over the past three consecutive sessions, reflecting a cumulative return of -3.21% during this period, underperforming its sector by 1.18% on the day.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
15-Dec-2025 | Source : BSENewspaper Publication- Special Window for Re-Lodgement of Transfer requests of Physical Shares.
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
02-Dec-2025 | Source : BSEThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on December 01 2025 for Hrishikesh Arvind Mafatlal as a Trustee of (Gurukripa Trust)
Announcement under Regulation 30 (LODR)-Demise
18-Nov-2025 | Source : BSEAnnouncement under Regulation 30 -Demise of an Independent Director
Corporate Actions 
No Upcoming Board Meetings
Nocil Ltd. has declared 20% dividend, ex-date: 30 Jul 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Non Institution
13.166
Held by 9 Schemes (5.55%)
Held by 73 FIIs (5.15%)
Hrishikesh Arvind Mafatlal(as A Trustee Of Gurukripa Trust) (18.16%)
Icici Prudential Smallcap Fund (3.55%)
44.0%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is -4.66% vs -1.02% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -29.78% vs -16.98% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -10.63% vs -1.70% in Sep 2024
Growth in half year ended Sep 2025 is -57.54% vs 12.58% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is -3.23% vs -11.09% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -10.24% vs -24.31% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -3.60% vs -10.63% in Mar 2024
YoY Growth in year ended Mar 2025 is -22.66% vs -10.83% in Mar 2024






